{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:01:52Z","timestamp":1784952112039,"version":"3.55.0"},"reference-count":21,"publisher":"Pharmaceutical Society of Japan","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,7,24]]},"DOI":"10.1248\/bpb.b26-00011","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T22:11:24Z","timestamp":1784844684000},"page":"1153-1160","source":"Crossref","is-referenced-by-count":0,"title":["Preventive Effects of Non-sedating and Sedating Histamine H&lt;sub&gt;1&lt;\/sub&gt; Receptor Antagonists Premedication for Subcutaneous Daratumumab-Associated Infusion-Related Reactions: A Prospective Observational Study"],"prefix":"10.1248","volume":"49","author":[{"given":"Mayu","family":"Yakumaru-Suzukawa","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacy, Keio University Graduate School of Pharmaceutical Sciences, 1\u20135\u201330 Shibakoen, Minato-ku, Tokyo 105\u20138512, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Aomori","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Takasaki University of Health and Welfare, 37\u20131 Nakaorui-machi, Takasaki, Gunma 370\u20130033, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norifumi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Hospital Organization Sendai Medical Center, 2\u201311\u201322 Miyagino, Miyagino-ku, Sendai 983\u20138520, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohata","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Gifu University Hospital, 1\u20131 Yanagido, Gifu 501\u20131194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Abumiya","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Akita University Hospital, 44\u20132 Hasunuma, Hiroomote, Akita 010\u20138543, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiyoshi","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Gunma Prefectural Cancer Center, 617\u20131 Takahayashinishi-cho, Ota, Gunma 373\u20130828, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoe","family":"Yoshizawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tochigi Cancer Center, 4\u20139\u201313 Yohnan, Utsunomiya, Tochigi 320\u20130834, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yamanashi Central Hospital, 1\u20131\u20131 Fujimi, Kofu, Yamanashi 400\u20138506, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Cancer Center, 5\u20131\u20131 Tsukiji, Chuo-ku, Tokyo 104\u20130045, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Suehiro","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160\u20138582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Hishida-Sadaka","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Gifu University Hospital, 1\u20131 Yanagido, Gifu 501\u20131194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Akita University Hospital, 44\u20132 Hasunuma, Hiroomote, Akita 010\u20138543, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinami","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Gunma Prefectural Cancer Center, 617\u20131 Takahayashinishi-cho, Ota, Gunma 373\u20130828, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tochigi Cancer Center, 4\u20139\u201313 Yohnan, Utsunomiya, Tochigi 320\u20130834, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Wakatsuki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yamanashi Central Hospital, 1\u20131\u20131 Fujimi, Kofu, Yamanashi 400\u20138506, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroomi","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160\u20138582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serika","family":"Banno-Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Gifu University Hospital, 1\u20131 Yanagido, Gifu 501\u20131194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Fukushi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Akita University Hospital, 44\u20132 Hasunuma, Hiroomote, Akita 010\u20138543, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Iihara","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Gifu University Hospital, 1\u20131 Yanagido, Gifu 501\u20131194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Akita University Hospital, 44\u20132 Hasunuma, Hiroomote, Akita 010\u20138543, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0626-7908","authenticated-orcid":false,"given":"Hitoshi","family":"Kawazoe","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Keio University Graduate School of Pharmaceutical Sciences, 1\u20135\u201330 Shibakoen, Minato-ku, Tokyo 105\u20138512, Japan"},{"name":"Department of Pharmacy, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160\u20138582, Japan"},{"name":"Department of Clinical Pharmacy, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160\u20138582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisakazu","family":"Ohtani","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Keio University Graduate School of Pharmaceutical Sciences, 1\u20135\u201330 Shibakoen, Minato-ku, Tokyo 105\u20138512, Japan"},{"name":"Department of Pharmacy, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160\u20138582, Japan"},{"name":"Department of Clinical Pharmacy, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160\u20138582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 (2017)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Barroso A, Estevinho F, Hespanhol V, Teixeira E, Ramalho-Carvalho J, Ara\u00fajo A. Management of infusion-related reactions in cancer therapy: strategies and challenges. <i>ESMO Open<\/i>, <b>9<\/b>, 102922 (2024).","DOI":"10.1016\/j.esmoop.2024.102922"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Zhang D, Tashiro M, Shibuya K, Okamura N, Funaki Y, Yoshikawa T, Kato M, Yanai K. Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography. <i>J. Clin. Psychopharmacol.<\/i>, <b>30<\/b>, 694\u2013701 (2010).","DOI":"10.1097\/JCP.0b013e3181fa8526"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Okamura N, Yanai K, Higuchi M, Sakai J, Iwata R, Ido T, Sasaki H, Watanabe T, Itoh M. Functional neuroimaging of cognition impaired by a classical antihistamine, <i>d<\/i>-chlorpheniramine. <i>Br. J. Pharmacol.<\/i>, <b>129<\/b>, 115\u2013123 (2000).","DOI":"10.1038\/sj.bjp.0702994"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Pradelli L, Massaia M, Todisco E, Gherlinzoni F, Furlan A, La Targia M, Grande E, Tripoli IE, Occhipinti F, Comello F, Iannello F, Bellucci S. Improved efficiency of daratumumab treatment of multiple myeloma adopting the subcutaneous route: a micro-costing analysis in three Italian hematology centers. <i>Cancer Med.<\/i>, <b>12<\/b>, 21480\u201321489 (2023).","DOI":"10.1002\/cam4.6699"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Davis JA, Youngberg H, Gaffney K, Duco M, Hashmi H. \u2018Fast but not so Furious\u2019: short observation time after subcutaneous Daratumumab administration is both a safe and cost-effective strategy. <i>Clin. Lymphoma Myeloma Leuk.<\/i>, <b>22<\/b>, e680\u2013e684 (2022).","DOI":"10.1016\/j.clml.2022.03.006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Slavcev M, Spinelli A, Absalon E, Masterson T, Heuck C, Lam A, De Cock E. Results of a time and motion survey regarding subcutaneous <i>versus<\/i> intravenous administration of daratumumab in patients with relapsed or refractory multiple myeloma. <i>Clinicoecon. Outcomes Res.<\/i>, <b>13<\/b>, 465\u2013473 (2021).","DOI":"10.2147\/CEOR.S302682"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Durham CG, Thotakura D, Sager L, Foster J, Herrington JD. Cetirizine <i>versus<\/i> diphenhydramine in the prevention of chemotherapy-related hypersensitivity reactions. <i>J. Oncol. Pharm. Pract.<\/i>, <b>25<\/b>, 1396\u20131401 (2019).","DOI":"10.1177\/1078155218811505"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Holmes JP, Peguero JA, Garland RC, North J, Young S, Brent LD, Joseph-Ridge N. Intravenous cetirizine <i>vs<\/i>. intravenous diphenhydramine for the prevention of hypersensitivity infusion reactions: results of an exploratory phase 2 study. <i>J. Infus. Nurs.<\/i>, <b>44<\/b>, 315\u2013322 (2021).","DOI":"10.1097\/NAN.0000000000000444"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Beaucage-Charron J, Gaudet L, Lamothe S, Pelletier C, P\u00e9pin A-S, Roy V, Charpentier F, Lordkipanidz\u00e9 M, Projean D, Bouchard P, Picard M. A randomized double-blind feasibility study comparing cetirizine and diphenhydramine in the prevention of paclitaxel-associated infusion-related reactions: the PREMED-F1 study. <i>Support. Care Cancer<\/i>, <b>30<\/b>, 3389\u20133399 (2022).","DOI":"10.1007\/s00520-021-06734-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yanai K, Yoshikawa T, Yanai A, Nakamura T, Iida T, Leurs R, Tashiro M. The clinical pharmacology of non-sedating antihistamines. <i>Pharmacol. Ther.<\/i>, <b>178<\/b>, 148\u2013156 (2017).","DOI":"10.1016\/j.pharmthera.2017.04.004"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Rombouts MD, Swart EL, Van Den Eertwegh AJM, Crul M. Systematic review on infusion reactions to and infusion rate of monoclonal antibodies used in cancer treatment. <i>Anticancer Res.<\/i>, <b>40<\/b>, 1201\u20131218 (2020).","DOI":"10.21873\/anticanres.14062"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Herscovitch J, Broughton R. Sensitivity of the Stanford sleepiness scale to the effects of cumulative partial sleep deprivation and recovery oversleeping. <i>Sleep<\/i>, <b>4<\/b>, 83\u201391 (1981).","DOI":"10.1093\/sleep\/4.1.83"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. <i>Sleep<\/i>, <b>14<\/b>, 540\u2013545 (1991).","DOI":"10.1093\/sleep\/14.6.540"},{"key":"15","unstructured":"15) Minakata D, Nagayama T, Iizuka C, <i>et al<\/i>. Safety evaluation of the initial subcutaneous administration of daratumumab for multiple myeloma and light-chain amyloidosis in an outpatient setting. <i>Int. J. Myeloma<\/i>, <b>14<\/b>, 19\u201325 (2024)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Iida S, Ishikawa T, Min CK, Kim K, Yeh SP, Usmani SZ, Mateos M-V, Nahi H, Heuck C, Qin X, Parasrampuria DA, Gries KS, Qi M, Bahlis N, Ito S. Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study. <i>Ann. Hematol.<\/i>, <b>100<\/b>, 1065\u20131077 (2021).","DOI":"10.1007\/s00277-021-04405-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Smoot K, Marginean H, Gervasi-Follmar T, Chen C. Comparing the risk of infusion-related reactions and tolerability in patients given cetirizine or diphenhydramine prior to ocrelizumab infusion (PRECEPT). <i>Medicina<\/i>, <b>60<\/b>, 659 (2024).","DOI":"10.3390\/medicina60040659"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Malmberg R, van Doorn L, Cox JM, Daloul A, Ettafahi H, Oomen-de Hoop E, Zietse M, Bos MEMM, Koch BCP, van Leeuwen RWF. Effect of switching the histamine-1 receptor antagonist clemastine to cetirizine in paclitaxel premedication regimens: the H<sub>1<\/sub>-switch study. <i>JCO Oncol. Pract.<\/i>, <b>20<\/b>, 1243\u20131251 (2024).","DOI":"10.1200\/OP.24.00110"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Tashiro M, Sakurada Y, Iwabuchi K, Mochizuki H, Kato M, Aoki M, Funaki Y, Itoh M, Iwata R, Wong DF, Yanai K. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H<sub>1<\/sub>-receptor occupancy using <sup>11<\/sup>C-doxepin positron emission tomography. <i>J. Clin. Pharmacol.<\/i>, <b>44<\/b>, 890\u2013900 (2004).","DOI":"10.1177\/0091270004267590"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tashiro M, Duan X, Kato M, Miyake M, Watanuki S, Ishikawa Y, Funaki Y, Iwata R, Itoh M, Yanai K. Brain histamine H<sub>1<\/sub> receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with <sup>11<\/sup>C-doxepin. <i>Br. J. Clin. Pharmacol.<\/i>, <b>65<\/b>, 811\u2013821 (2008).","DOI":"10.1111\/j.1365-2125.2008.03143.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Takegami M, Suzukamo Y, Wakita T, Noguchi H, Chin K, Kadotani H, Inoue Y, Oka Y, Nakamura T, Green J, Johns MW, Fukuhara S. Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theory. <i>Sleep Med.<\/i>, <b>10<\/b>, 556\u2013565 (2009).","DOI":"10.1016\/j.sleep.2008.04.015"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/7\/49_b26-00011\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:22:57Z","timestamp":1784949777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/7\/49_b26-00011\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00011","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"article-number":"b26-00011"}}